Profile data is unavailable for this security.
About the company
Aurisco Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development, production and sales of specialty active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. The Company's main products are respiratory, cardiovascular, anti-infective and nervous system drugs, including flumethasone, fluticasone propionate, eplerenone, tenofovir, pregabalin and other APIs and intermediates. The Company distributes its products in domestic market and to overseas markets.
- Revenue in CNY (TTM)1.30bn
- Net income in CNY325.73m
- Incorporated1998
- Employees1.52k
- LocationAurisco Pharmaceutical Co LtdNo. 1 Longxing RoadBadu Industrial Park, Tiantai CountyTAIZHOU 317200ChinaCHN
- Phone+86 57 683170900
- Fax+86 57 683170900
- Websitehttps://www.aurisco.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zhejiang Hisun Pharmaceutical Co., Ltd. | 10.04bn | -76.94m | 8.44bn | 8.06k | -- | 1.02 | -- | 0.8413 | -0.0823 | -0.0823 | 8.45 | 6.86 | 0.5535 | 3.32 | 4.53 | 1,244,871.00 | -0.5084 | 1.95 | -0.8569 | 3.77 | 38.35 | 40.58 | -0.9187 | 3.43 | 0.6303 | -- | 0.4158 | 26.07 | -13.82 | 0.3618 | -119.05 | -- | -31.58 | -- |
| Shanghai Runda Medical Technology Co Ltd | 9.04bn | 214.86m | 8.63bn | 3.32k | 38.75 | 2.00 | -- | 0.9544 | 0.3719 | 0.3719 | 15.65 | 7.22 | 0.6219 | 4.66 | 1.56 | 2,727,524.00 | 2.55 | 4.78 | 7.04 | 12.86 | 26.02 | 27.13 | 4.10 | 6.36 | 1.06 | 7.84 | 0.5568 | 12.43 | -12.84 | 8.93 | -34.58 | 0.8514 | 3.88 | 1.03 |
| Bio-Thera Solutions Ltd | 711.46m | -370.90m | 8.77bn | 1.17k | -- | 8.01 | -- | 12.32 | -0.8957 | -0.8957 | 1.72 | 2.64 | 0.3099 | 0.9439 | 6.06 | 609,647.70 | -16.15 | -23.62 | -23.70 | -30.81 | 71.41 | 79.76 | -52.13 | -106.72 | 0.8258 | -367.55 | 0.3515 | -- | 54.86 | -- | 17.87 | -- | -3.78 | -- |
| Aurisco Pharmaceutical Co Ltd | 1.30bn | 325.73m | 9.00bn | 1.52k | 27.60 | 4.33 | -- | 6.95 | 0.803 | 0.803 | 3.18 | 5.12 | 0.5404 | 1.17 | 4.99 | 852,082.90 | 13.57 | 12.40 | 16.46 | 14.33 | 56.90 | 51.26 | 25.12 | 23.05 | 1.72 | -- | 0.116 | 25.15 | 25.24 | 17.02 | 37.23 | 16.16 | 26.54 | -- |
| Jiangsu Kanion Pharmaceutical Co., Ltd. | 4.87bn | 543.34m | 9.06bn | 5.44k | 16.68 | 1.69 | -- | 1.86 | 0.9342 | 0.9342 | 8.39 | 9.22 | 0.6915 | 3.50 | 6.92 | 895,523.30 | 7.82 | 6.68 | 10.54 | 9.49 | 72.55 | 74.02 | 11.31 | 10.28 | 2.23 | -- | 0.00 | 25.57 | 11.88 | 4.94 | 23.54 | 5.33 | -1.87 | 35.99 |
| Guobang Pharma Ltd | 5.28bn | 616.22m | 9.35bn | 4.23k | 15.18 | 1.23 | -- | 1.77 | 1.10 | 1.10 | 9.44 | 13.61 | 0.5231 | 2.78 | 8.16 | 1,247,457.00 | 6.08 | 10.36 | 7.86 | 14.24 | 22.91 | 27.49 | 11.63 | 15.01 | 1.82 | -- | 0.2047 | 18.24 | -6.49 | 10.28 | -33.49 | 23.77 | 35.60 | -- |
| Joinn Laboratories China Co Ltd | 2.33bn | -62.99m | 9.39bn | 2.50k | -- | 1.25 | -- | 4.03 | -0.0862 | -0.0862 | 3.12 | 10.75 | 0.23 | 0.6906 | 8.14 | -- | -0.6856 | 8.99 | -0.8219 | 11.07 | 39.46 | 46.76 | -2.98 | 32.01 | 3.51 | 0.9996 | 0.0079 | 23.81 | 4.78 | 42.20 | -63.04 | 29.66 | 8.21 | 23.46 |
Data as of Jun 26 2024. Currency figures normalised to Aurisco Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
3.60%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| China Asset Management Co., Ltd.as of 31 Dec 2023 | 5.76m | 1.46% |
| Guotai Asset Management Co., Ltd.as of 30 Sep 2022 | 2.93m | 0.74% |
| SWS MU Fund Management Co., Ltd.as of 31 Dec 2023 | 1.55m | 0.39% |
| China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 1.29m | 0.33% |
| Broad Fund Management Co. Ltd.as of 31 Dec 2023 | 941.30k | 0.24% |
| Chang Xin Asset Management Co., Ltd.as of 31 Dec 2023 | 787.50k | 0.20% |
| Huashang Fund Management Co., Ltd.as of 31 Dec 2023 | 500.00k | 0.13% |
| VanEck Australia Pty Ltd.as of 07 Jun 2024 | 183.40k | 0.05% |
| Zhong Ou Asset Management Co., Ltdas of 31 Dec 2023 | 180.90k | 0.05% |
| Fuanda Fund Management Co., Ltd.as of 31 Dec 2023 | 124.40k | 0.03% |
More ▼
Data from 31 Dec 2023 - 20 Jun 2024Source: FactSet Research Systems Inc.
